MicroRNAs in metabolism and metabolic disorders
By V. Rottiers, Anders M. Näär. Nature reviews. Molecular cell biology, 2012
1,104 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/013c8f16f09128c10915f74cc7a9f0e9a74233da
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Tiangang Li
- J. Y. Chiang
- Laurent Farinelli
- J. Bohacek
- J. Prados
- I. Mansuy
- E. Miska
- P. Sarkies
Citations in the corpus
- Bile Acid Signaling in Metabolic Disease and Drug Therapy (2014, background): “miR-34a and miR-24 have emerged as key regulators of hepatic lipid metabolism (Rottiers and Näär, 2012).”
- Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice (2014, background): “78 protein: t(4)=5,14), confirming that miR-375 targets Ctnnb1.”
- Development of microRNA therapeutics is coming of age (2014, unknown): “In this section, we review selected examples, in which pharmacological modulation of miRNA activity has demonstrated a therapeutic benefit for the treatment of cancer, heart failure, atherosclerosis and HCV infection, respectively.”